Oncolytic Virotherapy Market Industry Analysis, Size, Share, Growth, Trends, and Forecast 2029
Research Nester released a report titled “Oncolytic Virotherapy Market: Global Demand Analysis & Opportunity Outlook 2029″ which delivers detailed overview of the oncolytic virotherapy market in terms of market segmentation by cancer type, application and region.
Further, for the
in-depth analysis, the report encompasses the industry growth indicators,
restraints, supply and demand risk, along with detailed discussion on current
and future market trends that are associated with the growth of the market.
The oncolytic virotherapy marketis projected to grow with a high
CAGR during the forecast period, i.e., 2021-2029 on account of the increase in
research and development on cancer treatment using oncolytic virotherapy and
the rising prevalence of cancer. According
to the data collected from International Agency for Research on Cancer (IARC),
in 2020, the projected new cases and deaths from cancer globally were 19.3
million and 10 million, respectively.
Request Sample Data To Learn More About This Report @ https://www.researchnester.com/sample-request-2988
The market is
segmented by cancer type into melanoma, prostate cancer, breast cancer, ovarian
cancer and others. Among these, the breast cancer segment is anticipated to
hold the largest share by the end of 2021 in the oncolytic virotherapy marketas
it is the most common kind of cancer worldwide. It is also gaining worldwide
recognition for having increased treatment efficacy for advanced breast cancer
and thus, provides a unique platform for personalized treatments in such
patients. On the basis of application, the market is divided into general
medical & surgical hospitals, speciality hospitals, clinics, and others. On
the basis of region, the market is segmented into North America, Europe, Asia
Pacific, Latin America, and the Middle East & Africa, out of which, the
oncolytic virotherapy market in the Asia Pacific is projected to grow at the
highest CAGR throughout the forecast period. Currently, the market in North
America holds the largest share. This can be attributed to the presence of
leading healthcare providers in the region, especially in the United States,
who are extensively involved in the research and development for innovative
cancer treatment procedures.
Increasing Prevalence of Cancer and Increased Research and
Development on Cancer Treatment using Oncolytic Virotherapy
According to International Agency for Research on Cancer
(IARC), it is projected that by 2040, the number of new cancer cases per year
is likely to rise to 29.5 million and the number of cancer related deaths to
16.4 million.
Unhealthy lifestyle is
one of the most predominant risk factors for any kind of cancer. It has been
observed that individuals who consume tobacco or alcohol on a regular basis
possess a high risk of having cancer. Additionally, the increased focus on
research for cancer treatment in recent years is also expected to boost the
market growth in upcoming years. However, a number of oncolytic virotherapy
treatments are currently in clinical trial phase and along with this, there is
a lack of awareness about the disease in low income economies which is
estimated to restrain market growth in the near future.
This report also
provides the existing competitive scenario of some of the key players of the
oncolytic virotherapy market which includes company profiling of Amgen, Inc.
(NASDAQ: AMGN), Oncolytics Biotech (TSE: ONC), Viralytics Ltd., Transgene SA
(EPA; TNG), Shanghai Sunway Biotech Co. Ltd., Replimune Group, Inc., Sorrento
Therapeutics, Inc. (NASDAQ: SRNE), SillaJen, Inc., and Oncorus, Inc.
Request Sample Data To Learn More About This Report @ https://www.researchnester.com/sample-request-2988
The profiling enfolds
key information of the companies which encompasses business overview, products
and services, key financials and recent news and developments. On the whole,
the report depicts detailed overview of the oncolytic virotherapy market that
will help industry consultants, equipment manufacturers, existing players
searching for expansion opportunities, new players searching possibilities and
other stakeholders to align their market centric strategies according to the
ongoing and expected trends in the future.
About Research Nester:
Research Nester is a
one-stop service provider with a client base in more than 50 countries, leading
in strategic market research and consulting with an unbiased and unparalleled
approach towards helping global industrial players, conglomerates and
executives for their future investment while avoiding forthcoming
uncertainties. With an out-of-the-box mindset to produce statistical and
analytical market research reports, we provide strategic consulting so that our
clients can make wise business decisions with clarity while strategizing and
planning for their forthcoming needs and succeed in achieving their future
endeavors. We believe every business can expand to its new horizon, provided a
right guidance at a right time is available through strategic minds.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Comments
Post a Comment